BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Company News  |  Deals

Active Biotech, Ipsen deal

Active Biotech partnered with Ipsen to co-develop and commercialize Active Biotech's cancer candidate tasquinimod ( TASQ). Active Biotech will be responsible for completing an ongoing...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >